Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Genetic testing in inherited endocrine disorders: joint position paper of the European reference network on rare endocrine conditions (Endo-ERN)

Publikation: Bidrag til tidsskriftReviewpeer review

DOI

  1. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The calcium-sensing receptor is essential for calcium and bicarbonate sensitivity in human spermatozoa

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Establishment of a novel human fetal adrenal culture model that supports de novo and manipulated steroidogenesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Possible Relevance of Soluble Luteinizing Hormone Receptor during Development and Adulthood in Boys and Men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. CPMS-improving patient care in Europe via virtual case discussions

    Publikation: Bidrag til tidsskriftReviewpeer review

  • Thomas Eggermann
  • Miriam Elbracht
  • Ingo Kurth
  • Anders Juul
  • Trine Holm Johannsen
  • Irène Netchine
  • George Mastorakos
  • Gudmundur Johannsson
  • Thomas J Musholt
  • Martin Zenker
  • Dirk Prawitt
  • Alberto M Pereira
  • Olaf Hiort
  • European Reference Network on Rare Endocrine Conditions (ENDO-ERN
Vis graf over relationer

BACKGROUND: With the development of molecular high-throughput assays (i.e. next generation sequencing), the knowledge on the contribution of genetic and epigenetic alterations to the etiology of inherited endocrine disorders has massively expanded. However, the rapid implementation of these new molecular tools in the diagnostic settings makes the interpretation of diagnostic data increasingly complex.

MAIN BODY: This joint paper of the ENDO-ERN members aims to overview chances, challenges, limitations and relevance of comprehensive genetic diagnostic testing in rare endocrine conditions in order to achieve an early molecular diagnosis. This early diagnosis of a genetically based endocrine disorder contributes to a precise management and helps the patients and their families in their self-determined planning of life. Furthermore, the identification of a causative (epi)genetic alteration allows an accurate prognosis of recurrence risks for family planning as the basis of genetic counselling. Asymptomatic carriers of pathogenic variants can be identified, and prenatal testing might be offered, where appropriate.

CONCLUSIONS: The decision on genetic testing in the diagnostic workup of endocrine disorders should be based on their appropriateness to reliably detect the disease-causing and -modifying mutation, their informational value, and cost-effectiveness. The future assessment of data from different omic approaches should be embedded in interdisciplinary discussions using all available clinical and molecular data.

OriginalsprogEngelsk
TidsskriftOrphanet Journal of Rare Diseases
Vol/bind15
Udgave nummer1
Sider (fra-til)144
ISSN1750-1172
DOI
StatusUdgivet - 8 jun. 2020

ID: 60160497